4. Cost-effectiveness of generic pan-genotypic sofosbuvir/velpatasvir versus genotype-dependent direct- acting antivirals for hepatitis C treatment

2018 ◽  
Vol 8 ◽  
pp. S14 ◽  
Author(s):  
Amit Goel ◽  
Qiushi Chen ◽  
Jagpreet Chhatwal ◽  
Rakesh Aggarwal
Keyword(s):  
Cost Effectiveness ◽  
Hepatitis C ◽  
Direct Acting Antivirals ◽  
Hepatitis C Treatment ◽  
Direct Acting

scholarly journals Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India

PLoS ONE ◽  
2017 ◽  
Vol 12 (5) ◽  
pp. e0176503 ◽  
Author(s):  
Rakesh Aggarwal ◽  
Qiushi Chen ◽  
Amit Goel ◽  
Nicole Seguy ◽  
Razia Pendse ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Hepatitis C ◽  
Direct Acting Antivirals ◽  
Hepatitis C Treatment ◽  
Direct Acting

scholarly journals Cost-Effectiveness of Hepatitis C Treatment using Generic Direct-Acting Antivirals Available in India

2017 ◽  
Vol 7 ◽  
pp. S22-S23
Author(s):  
Rakesh Aggarwal ◽  
Qiushi Chen ◽  
Amit Goel ◽  
Nicole Seguy ◽  
Razia Pendse ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Hepatitis C ◽  
Direct Acting Antivirals ◽  
Hepatitis C Treatment ◽  
Direct Acting

scholarly journals Cost Effectiveness of Pre– vs Post–Liver Transplant Hepatitis C Treatment With Direct-Acting Antivirals

2018 ◽  
Vol 16 (1) ◽  
pp. 115-122.e10 ◽  
Author(s):  
Sumeyye Samur ◽  
Brian Kues ◽  
Turgay Ayer ◽  
Mark S. Roberts ◽  
Fasiha Kanwal ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Hepatitis C ◽  
Liver Transplant ◽  
Direct Acting Antivirals ◽  
Hepatitis C Treatment ◽  
Direct Acting
Sign in / Sign up

Export Citation Format

Share Document